ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global End Stage Renal Disease Treatment Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-2F6212
Home | Market Reports
Global End Stage Renal Disease Treatment Market Research Report 2022
BUY CHAPTERS

Global End Stage Renal Disease Treatment Market Research Report 2026

Code: QYRE-Auto-2F6212
Report
2026-03-31
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
NIKKISO
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Sanxin Medtec

End Stage Renal Disease Treatment Market Size

The global End Stage Renal Disease Treatment market was valued at US$ 60910 million in 2025 and is anticipated to reach US$ 87910 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

End Stage Renal Disease Treatment Market

End Stage Renal Disease Treatment Market

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report delivers a comprehensive overview of the global End Stage Renal Disease Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding End Stage Renal Disease Treatment. The End Stage Renal Disease Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global End Stage Renal Disease Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist End Stage Renal Disease Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of End Stage Renal Disease Treatment Market Report

Report Metric Details
Report Name End Stage Renal Disease Treatment Market
Accounted market size in 2025 US$ 60910 million
Forecasted market size in 2032 US$ 87910 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Hemodialysis
  • Peritoneal Dialysis
  • Kidney Transplantation
Segment by Application
  • Hospitals
  • Kidney Dialysis Centers
  • At Homes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for End Stage Renal Disease Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is End Stage Renal Disease Treatment Market growing?

Ans: The End Stage Renal Disease Treatment Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the End Stage Renal Disease Treatment Market size in 2032?

Ans: The End Stage Renal Disease Treatment Market size in 2032 will be US$ 87910 million.

What is the Fresenius, DaVita, Baxter share in End Stage Renal Disease Treatment Market?

Ans: Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc.

What is the End Stage Renal Disease Treatment Market share by type?

Ans: In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.

Who are the main players in the End Stage Renal Disease Treatment Market report?

Ans: The main players in the End Stage Renal Disease Treatment Market are Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical

What are the Application segmentation covered in the End Stage Renal Disease Treatment Market report?

Ans: The Applications covered in the End Stage Renal Disease Treatment Market report are Hospitals, Kidney Dialysis Centers, At Homes, Others

What are the Type segmentation covered in the End Stage Renal Disease Treatment Market report?

Ans: The Types covered in the End Stage Renal Disease Treatment Market report are Hemodialysis, Peritoneal Dialysis, Kidney Transplantation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End Stage Renal Disease Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Hemodialysis
1.2.3 Peritoneal Dialysis
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global End Stage Renal Disease Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global End Stage Renal Disease Treatment Market Perspective (2021–2032)
2.2 Global End Stage Renal Disease Treatment Growth Trends by Region
2.2.1 Global End Stage Renal Disease Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 End Stage Renal Disease Treatment Historic Market Size by Region (2021–2026)
2.2.3 End Stage Renal Disease Treatment Forecasted Market Size by Region (2027–2032)
2.3 End Stage Renal Disease Treatment Market Dynamics
2.3.1 End Stage Renal Disease Treatment Industry Trends
2.3.2 End Stage Renal Disease Treatment Market Drivers
2.3.3 End Stage Renal Disease Treatment Market Challenges
2.3.4 End Stage Renal Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top End Stage Renal Disease Treatment Players by Revenue
3.1.1 Global Top End Stage Renal Disease Treatment Players by Revenue (2021–2026)
3.1.2 Global End Stage Renal Disease Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top End Stage Renal Disease Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by End Stage Renal Disease Treatment Revenue
3.4 Global End Stage Renal Disease Treatment Market Concentration Ratio
3.4.1 Global End Stage Renal Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease Treatment Revenue in 2025
3.5 Global Key Players of End Stage Renal Disease Treatment Head Offices and Areas Served
3.6 Global Key Players of End Stage Renal Disease Treatment, Products and Applications
3.7 Global Key Players of End Stage Renal Disease Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 End Stage Renal Disease Treatment Breakdown Data by Type
4.1 Global End Stage Renal Disease Treatment Historic Market Size by Type (2021–2026)
4.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2027–2032)
5 End Stage Renal Disease Treatment Breakdown Data by Application
5.1 Global End Stage Renal Disease Treatment Historic Market Size by Application (2021–2026)
5.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America End Stage Renal Disease Treatment Market Size (2021–2032)
6.2 North America End Stage Renal Disease Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America End Stage Renal Disease Treatment Market Size by Country (2021–2026)
6.4 North America End Stage Renal Disease Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe End Stage Renal Disease Treatment Market Size (2021–2032)
7.2 Europe End Stage Renal Disease Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe End Stage Renal Disease Treatment Market Size by Country (2021–2026)
7.4 Europe End Stage Renal Disease Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific End Stage Renal Disease Treatment Market Size (2021–2032)
8.2 Asia-Pacific End Stage Renal Disease Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America End Stage Renal Disease Treatment Market Size (2021–2032)
9.2 Latin America End Stage Renal Disease Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America End Stage Renal Disease Treatment Market Size by Country (2021–2026)
9.4 Latin America End Stage Renal Disease Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa End Stage Renal Disease Treatment Market Size (2021–2032)
10.2 Middle East & Africa End Stage Renal Disease Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Details
11.1.2 Fresenius Business Overview
11.1.3 Fresenius End Stage Renal Disease Treatment Introduction
11.1.4 Fresenius Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Details
11.2.2 DaVita Business Overview
11.2.3 DaVita End Stage Renal Disease Treatment Introduction
11.2.4 DaVita Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter End Stage Renal Disease Treatment Introduction
11.3.4 Baxter Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Details
11.4.2 Nipro Business Overview
11.4.3 Nipro End Stage Renal Disease Treatment Introduction
11.4.4 Nipro Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun End Stage Renal Disease Treatment Introduction
11.5.4 B. Braun Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Details
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei End Stage Renal Disease Treatment Introduction
11.6.4 Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Details
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso End Stage Renal Disease Treatment Introduction
11.7.4 Nikkiso Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Details
11.8.2 WEGO Business Overview
11.8.3 WEGO End Stage Renal Disease Treatment Introduction
11.8.4 WEGO Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Details
11.9.2 Newsol Business Overview
11.9.3 Newsol End Stage Renal Disease Treatment Introduction
11.9.4 Newsol Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic End Stage Renal Disease Treatment Introduction
11.10.4 Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Details
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight End Stage Renal Disease Treatment Introduction
11.11.4 Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Details
11.12.2 Medtronic Business Overview
11.12.3 Medtronic End Stage Renal Disease Treatment Introduction
11.12.4 Medtronic Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Details
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec End Stage Renal Disease Treatment Introduction
11.13.4 Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Details
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical End Stage Renal Disease Treatment Introduction
11.14.4 Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Details
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Details
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical End Stage Renal Disease Treatment Introduction
11.16.4 Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (2021–2026)
11.16.5 Tianyi Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Medtronic Inc
NIKKISO
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Sanxin Medtec
List of Tables
 Table 1. Global End Stage Renal Disease Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Hemodialysis
 Table 3. Key Players of Peritoneal Dialysis
 Table 4. Key Players of Kidney Transplantation
 Table 5. Global End Stage Renal Disease Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global End Stage Renal Disease Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global End Stage Renal Disease Treatment Market Size by Region (US$ Million), 2021–2026
 Table 8. Global End Stage Renal Disease Treatment Market Share by Region (2021–2026)
 Table 9. Global End Stage Renal Disease Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global End Stage Renal Disease Treatment Market Share by Region (2027–2032)
 Table 11. End Stage Renal Disease Treatment Market Trends
 Table 12. End Stage Renal Disease Treatment Market Drivers
 Table 13. End Stage Renal Disease Treatment Market Challenges
 Table 14. End Stage Renal Disease Treatment Market Restraints
 Table 15. Global End Stage Renal Disease Treatment Revenue by Players (US$ Million), 2021–2026
 Table 16. Global End Stage Renal Disease Treatment Market Share by Players (2021–2026)
 Table 17. Global Top End Stage Renal Disease Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on End Stage Renal Disease Treatment Revenue, 2025
 Table 18. Ranking of Global Top End Stage Renal Disease Treatment Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by End Stage Renal Disease Treatment Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of End Stage Renal Disease Treatment, Headquarters and Area Served
 Table 21. Global Key Players of End Stage Renal Disease Treatment, Products and Applications
 Table 22. Global Key Players of End Stage Renal Disease Treatment, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global End Stage Renal Disease Treatment Market Size by Type (US$ Million), 2021–2026
 Table 25. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2021–2026)
 Table 26. Global End Stage Renal Disease Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2027–2032)
 Table 28. Global End Stage Renal Disease Treatment Market Size by Application (US$ Million), 2021–2026
 Table 29. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2021–2026)
 Table 30. Global End Stage Renal Disease Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2027–2032)
 Table 32. North America End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2021–2026
 Table 34. North America End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific End Stage Renal Disease Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa End Stage Renal Disease Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (US$ Million), 2027–2032
 Table 47. Fresenius Company Details
 Table 48. Fresenius Business Overview
 Table 49. Fresenius End Stage Renal Disease Treatment Product
 Table 50. Fresenius Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 51. Fresenius Recent Development
 Table 52. DaVita Company Details
 Table 53. DaVita Business Overview
 Table 54. DaVita End Stage Renal Disease Treatment Product
 Table 55. DaVita Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 56. DaVita Recent Development
 Table 57. Baxter Company Details
 Table 58. Baxter Business Overview
 Table 59. Baxter End Stage Renal Disease Treatment Product
 Table 60. Baxter Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 61. Baxter Recent Development
 Table 62. Nipro Company Details
 Table 63. Nipro Business Overview
 Table 64. Nipro End Stage Renal Disease Treatment Product
 Table 65. Nipro Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 66. Nipro Recent Development
 Table 67. B. Braun Company Details
 Table 68. B. Braun Business Overview
 Table 69. B. Braun End Stage Renal Disease Treatment Product
 Table 70. B. Braun Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 71. B. Braun Recent Development
 Table 72. Asahi Kasei Company Details
 Table 73. Asahi Kasei Business Overview
 Table 74. Asahi Kasei End Stage Renal Disease Treatment Product
 Table 75. Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 76. Asahi Kasei Recent Development
 Table 77. Nikkiso Company Details
 Table 78. Nikkiso Business Overview
 Table 79. Nikkiso End Stage Renal Disease Treatment Product
 Table 80. Nikkiso Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 81. Nikkiso Recent Development
 Table 82. WEGO Company Details
 Table 83. WEGO Business Overview
 Table 84. WEGO End Stage Renal Disease Treatment Product
 Table 85. WEGO Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 86. WEGO Recent Development
 Table 87. Newsol Company Details
 Table 88. Newsol Business Overview
 Table 89. Newsol End Stage Renal Disease Treatment Product
 Table 90. Newsol Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 91. Newsol Recent Development
 Table 92. Mayo Clinic Company Details
 Table 93. Mayo Clinic Business Overview
 Table 94. Mayo Clinic End Stage Renal Disease Treatment Product
 Table 95. Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 96. Mayo Clinic Recent Development
 Table 97. Guangdong Biolight Company Details
 Table 98. Guangdong Biolight Business Overview
 Table 99. Guangdong Biolight End Stage Renal Disease Treatment Product
 Table 100. Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 101. Guangdong Biolight Recent Development
 Table 102. Medtronic Company Details
 Table 103. Medtronic Business Overview
 Table 104. Medtronic End Stage Renal Disease Treatment Product
 Table 105. Medtronic Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 106. Medtronic Recent Development
 Table 107. Sanxin Medtec Company Details
 Table 108. Sanxin Medtec Business Overview
 Table 109. Sanxin Medtec End Stage Renal Disease Treatment Product
 Table 110. Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 111. Sanxin Medtec Recent Development
 Table 112. Jafron Biomedical Company Details
 Table 113. Jafron Biomedical Business Overview
 Table 114. Jafron Biomedical End Stage Renal Disease Treatment Product
 Table 115. Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 116. Jafron Biomedical Recent Development
 Table 117. SWS Hemodialysis Care Company Details
 Table 118. SWS Hemodialysis Care Business Overview
 Table 119. SWS Hemodialysis Care End Stage Renal Disease Treatment Product
 Table 120. SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 121. SWS Hemodialysis Care Recent Development
 Table 122. Tianyi Medical Company Details
 Table 123. Tianyi Medical Business Overview
 Table 124. Tianyi Medical End Stage Renal Disease Treatment Product
 Table 125. Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (US$ Million), 2021–2026
 Table 126. Tianyi Medical Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. End Stage Renal Disease Treatment Picture
 Figure 2. Global End Stage Renal Disease Treatment Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global End Stage Renal Disease Treatment Market Share by Type: 2025 vs 2032
 Figure 4. Hemodialysis Features
 Figure 5. Peritoneal Dialysis Features
 Figure 6. Kidney Transplantation Features
 Figure 7. Global End Stage Renal Disease Treatment Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global End Stage Renal Disease Treatment Market Share by Application: 2025 vs 2032
 Figure 9. Hospitals Case Studies
 Figure 10. Kidney Dialysis Centers Case Studies
 Figure 11. At Homes Case Studies
 Figure 12. Others Case Studies
 Figure 13. End Stage Renal Disease Treatment Report Years Considered
 Figure 14. Global End Stage Renal Disease Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global End Stage Renal Disease Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global End Stage Renal Disease Treatment Market Share by Region: 2025 vs 2032
 Figure 17. Global End Stage Renal Disease Treatment Market Share by Players in 2025
 Figure 18. Global End Stage Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by End Stage Renal Disease Treatment Revenue in 2025
 Figure 20. North America End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America End Stage Renal Disease Treatment Market Share by Country (2021–2032)
 Figure 22. United States End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe End Stage Renal Disease Treatment Market Share by Country (2021–2032)
 Figure 26. Germany End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific End Stage Renal Disease Treatment Market Share by Region (2021–2032)
 Figure 34. China End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America End Stage Renal Disease Treatment Market Share by Country (2021–2032)
 Figure 42. Mexico End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa End Stage Renal Disease Treatment Market Share by Country (2021–2032)
 Figure 46. Israel End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE End Stage Renal Disease Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Fresenius Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 50. DaVita Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 51. Baxter Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 52. Nipro Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 53. B. Braun Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 54. Asahi Kasei Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 55. Nikkiso Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 56. WEGO Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 57. Newsol Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 58. Mayo Clinic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 59. Guangdong Biolight Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 60. Medtronic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 61. Sanxin Medtec Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 62. Jafron Biomedical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 63. SWS Hemodialysis Care Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 64. Tianyi Medical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2021–2026)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Artificial Kidney Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global End Stage Renal Disease ESRD Device Market Research Report 2024
Global End Stage Renal Disease Market Research Report 2024
Global End Stage Kidney Disease Market Research Report 2024
End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CKD and ESRD Treatment Market Research Report 2025
Global End stage Renal Disease Therapeutics Market Research Report 2024
Global Renal Therapeutic Market Research Report 2025
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024
Global Renal Diseases Drug Market Insights Forecast to 2030
Global Hemodialysis and Peritoneal Dialysis Machine Market Research Report 2024
Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemodialysis Drug Market Research Report 2024
Global Dialysis Drug Market Research Report 2024
Global Hemodialysis Equipment and Consumable Market Research Report 2024
Global Dialysis Equipment and Consumable Market Research Report 2024
Global Chronic Kidney Disease Medication Market Research Report 2024
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions